Altre lingue Bavarian Nordic A/S

Azioni

BAVA

DK0015998017

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 17:20:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
175 ^DKK	+1,24%		+12,11%	-1,41%

01/07	Bavarian Nordic trasforma una linea di credito da 1 miliardo di corone danesi in un prestito legato alla sostenibilità	MT
28/06	Bavarian Nordic dona il vaccino Mpox per combattere l'epidemia africana	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bavarian Nordic Turns DKK1 Billion Facility into Sustainability-linked Loan	01/07
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan	01/07
Nordic Stocks Rose Friday; Millicom International Cellular Climbed Highest	28/06
Bavarian Nordic Donates Mpox Vaccine to Combat African Outbreak	28/06
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa	28/06
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa	28/06
Congo authorities approve mpox vaccines to try to contain outbreak	27/06
Congo authorities approve mpox vaccines to try to contain outbreak	26/06
Point marchés-L'Europe termine en baisse une séance marquée par les craintes sur l'inflation US	26/06
Bavarian Nordic Files EU Application for Chikungunya Vaccine Candidate	26/06
Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA	26/06
Bavarian Nordic A/S Submits Marketing Authorization Application for Its Chikungunya Vaccine Candidate to Ema	26/06
Bavarian Nordic Wraps Up US FDA's Biologics License Application for Chikungunya Vaccine Candidate	18/06
Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate	17/06
Tollwut-Impfstoff bald wieder verfügbar	14/06
High-risk health workers can get routine Ebola vaccine, Gavi says	13/06
High-risk health workers can get routine Ebola vaccine, says Gavi	13/06
Bavarian Nordic Files for Supplemental US License for Smallpox-Monkeypox Vaccine	31/05
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine	31/05
Bavarian Nordic Gets $6.5 Million Funding for Development of Mpox Vaccine in Children	30/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bavarian Nordic A/S

Azioni

BAVA

DK0015998017

Altre lingue

Filtri